BioSpace News Archive

Predicine, a global molecular insights company, is committed to advancing genitourinary cancer detection and treatment decisions through its proprietary non-invasive next-generation sequencing assays.

Ultragenyx Pharmaceutical Inc. reported its financial results for the quarter and full year ended December 31, 2022 and reaffirmed its financial guidance for 2023.

Artivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced its financial results for the fourth quarter and full year ended December 31, 2022.

PacBio announced financial results for the quarter and fiscal year ended December 31, 2022.

Nevro Corp. announced its fourth quarter and full-year 2022 financial results.

Maze Therapeutics announced that the company will present data from its first-in-human clinical trial of MZE001 in healthy volunteers at the WORLDSymposium 2023.

Paragon 28, Inc., a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the fourth quarter and full year 2022 after market close on Thursday, March 2, 2023.

AMN Healthcare Services, Inc., the leader and innovator in total talent solutions for healthcare organizations across the United States, announced its fourth quarter and full year 2022 financial results.

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced financial results for the fourth quarter and full year ended December 31, 2022.

Prothena Corporation plc, a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, announced that it will report its fourth quarter and full year 2022 financial results on Thursday, February 23, 2023 after the close of the U.S. financial markets.